Namibia host 2nd National Health Assembly

WHO Representative, Dr Charles Sagoe-Moses, at the 2nd National Health Assembly

Namibia hosted the 2nd National Health Assembly on 21 February to take stock of achievements of the past year and coordinate health interventions of partners in the country.  During his opening remarks, the Minister of Health and Social Services, Hon. Dr Kalumbi Shangula, reiterated the government’s commitment towards the health of its people which has translated in major milestones in the health sector.

WHO supports Government to mitigate measles, rubella outbreaks nationwide

A little boy suffering from Measles

Abuja, 28 February 2019 - As Nigeria experiences measles and rubella outbreaks, the World Health Organization (WHO) has constituted, in collaboration with the Nigerian government, an Emergency Preparedness and Response (EPR) team to mitigate further spread of measles and rubella in the country. 

Graduation of Field Epidemiology and Laboratory Training Program

Graduation of health workers in field epidemiology

Twenty four  (24) health care workers graduated from a 3 month programme on field epidemiology and laboratory training programme with support from WHO and CDC.  The trainees were selected from health districts affected by the ongoing HEP E virus outbreak.  Although the programme cuts across public health emergencies and threats, the trainees are expected to strengthen surveillance on hepatitis E virus and improve daily reporting of cases.  The training was a response to findings of the WHO Rapid Assessment report which highlighted active case search and weekly reporting

Strengthening surveillance for Guinea worm disease in Northern Namibia

Surveillance for Guinea worm disease in Northern Namibia

A case of Guinea worm disease (GWD) was confirmed in Angola in June 2018.  The case, an eight-year girl, hails from the Cunene Province in Angola, which borders Ohangwena and Omusati Regions in Namibia.  In response, Angolan authorities, with WHO support, carried out further case searches in three southern provinces of the country, including Cunene.

New Minister of Health Recommits government to end Hepatitis E Outbreak

Governor of the Khomas Region, Mrs. Laura Mcleod-Katjirua; Minister of Health and Social Services, Dr Kalumbi Shangula; WHO Representative, Dr. Charles Sagoe-Moses

The Ministry of Health and Social Services has recommitted itself to ending the Hepatitis E virus Outbreak which has claimed 41 lives since December 2017.  A National Health Emergency Management Committee was activated since confirmation of the outbreak and the Ministry has engaged partners and mobilized resources to respond to the outbreak.  Despite these control measures, the disease persists and has now spread to more than 7 of the 14 regions in the country. 

Strengthening surveillance for Guinea worm disease in Northern Namibia

dracunculiasis-guinea-worm-disease. Credit: WHO

A case of Guinea worm disease (GWD) was confirmed in Angola in June 2018.  The case, an eight-year girl, hails from the Cunene Province in Angola, which borders Ohangwena and Omusati Regions in Namibia.  In response, Angolan authorities, with WHO support, carried out further case searches in three southern provinces of the country, including Cunene. During the exercise, a suspected case was detected who, at the time of her illness, had travelled to Engela in Ohangwena Region for a wedding and was treated at the Engela District Hospital.

WHO ERITREA 2019 Staff retreat

Group photo

The WHO Country Office in Eritrea held the goals week in February 2019 organized as a retreat in the beautiful historic port of Massawa. It was a perfect opportunity to take a step back from the day-to-day work of the office and spend some time thinking about the big picture of the possible way forward for implementation of the GPW13 as a team.

6th set of meetings of the African Vaccine Regulatory Forum (AVAREF): AVAREF broadened beyond vaccines to include medicines

Participants of 6th AVAREF meeting
African Vaccine Regulatory Forum (AVAREF) was established by WHO in 2006 as a network of National Regulatory Authorities (NRAs) and Ethics Committees (ECs) of African countries providing a platform for building regulatory capacity and promoting harmonization of practices in support of oversight of clinical trials in the region. AVAREF has since played a crucial role in the successful development of several vaccines, notably the meningococcal A conjugate vaccine, whose licensure and rollout has dramatically reduced epidemics of meningococcal A meningitis. The capacity of AVAREF has now been broadened beyond vaccines and includes medicines.